Acquired platelet dysfunction and overproduction of platelet cyclic AMP in two patients with myeloid malignancies

The pathophysiology of impaired platelet function in acquired disorders is often poorly understood. We report two unrelated patients with hematologic malignancies associated with acquired severe bleeding diathesis, and complex platelet function abnormalities, including overproduction of the physiolo...

Full description

Bibliographic Details
Main Authors: Anna Lecchi, Eti A. Femia, Silvia La Marca, Francesco Onida, Andrea Artoni
Format: Article
Language:English
Published: Taylor & Francis Group 2019-11-01
Series:Platelets
Subjects:
Online Access:http://dx.doi.org/10.1080/09537104.2019.1636020
_version_ 1797684192866205696
author Anna Lecchi
Eti A. Femia
Silvia La Marca
Francesco Onida
Andrea Artoni
author_facet Anna Lecchi
Eti A. Femia
Silvia La Marca
Francesco Onida
Andrea Artoni
author_sort Anna Lecchi
collection DOAJ
description The pathophysiology of impaired platelet function in acquired disorders is often poorly understood. We report two unrelated patients with hematologic malignancies associated with acquired severe bleeding diathesis, and complex platelet function abnormalities, including overproduction of the physiological inhibitor cyclic-AMP (cAMP). Patient 1, with mild macrocytic anemia and thrombocytopenia (100 x 109/L), was diagnosed with chronic myelomonocytic leukemia a few months after the onset of her bleeding diathesis and our analysis of platelet function. Patient 2, with bleeding diathesis of recent onset, was studied when his myelodysplastic syndrome with excess blasts had already progressed to acute myeloid leukemia. In both patients, platelet aggregation/ATP secretion, serum thromboxane B2, intraplatelet content of ADP, ATP, serotonin, and fibrinogen were severely impaired. Baseline platelet cAMP levels were mildly elevated and markedly increased after stimulation by prostaglandin E1. In conclusion, these are the first patients with myeloid malignancies associated with acquired severe platelet dysfunction and overproduction of cAMP.
first_indexed 2024-03-12T00:26:56Z
format Article
id doaj.art-3c3f4dbdb75e485896618f6e56c3db90
institution Directory Open Access Journal
issn 0953-7104
1369-1635
language English
last_indexed 2024-03-12T00:26:56Z
publishDate 2019-11-01
publisher Taylor & Francis Group
record_format Article
series Platelets
spelling doaj.art-3c3f4dbdb75e485896618f6e56c3db902023-09-15T10:32:01ZengTaylor & Francis GroupPlatelets0953-71041369-16352019-11-013081053105610.1080/09537104.2019.16360201636020Acquired platelet dysfunction and overproduction of platelet cyclic AMP in two patients with myeloid malignanciesAnna Lecchi0Eti A. Femia1Silvia La Marca2Francesco Onida3Andrea Artoni4Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis CenterFondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis CenterFondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis CenterFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Università degli Studi di Milano, Department of Oncology and Hemato-Oncology, BMT CenterFondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis CenterThe pathophysiology of impaired platelet function in acquired disorders is often poorly understood. We report two unrelated patients with hematologic malignancies associated with acquired severe bleeding diathesis, and complex platelet function abnormalities, including overproduction of the physiological inhibitor cyclic-AMP (cAMP). Patient 1, with mild macrocytic anemia and thrombocytopenia (100 x 109/L), was diagnosed with chronic myelomonocytic leukemia a few months after the onset of her bleeding diathesis and our analysis of platelet function. Patient 2, with bleeding diathesis of recent onset, was studied when his myelodysplastic syndrome with excess blasts had already progressed to acute myeloid leukemia. In both patients, platelet aggregation/ATP secretion, serum thromboxane B2, intraplatelet content of ADP, ATP, serotonin, and fibrinogen were severely impaired. Baseline platelet cAMP levels were mildly elevated and markedly increased after stimulation by prostaglandin E1. In conclusion, these are the first patients with myeloid malignancies associated with acquired severe platelet dysfunction and overproduction of cAMP.http://dx.doi.org/10.1080/09537104.2019.1636020blood platelet disorderscyclic ampmyelodysplastic syndrome (mds)myeloid leukemiaplatelet function tests
spellingShingle Anna Lecchi
Eti A. Femia
Silvia La Marca
Francesco Onida
Andrea Artoni
Acquired platelet dysfunction and overproduction of platelet cyclic AMP in two patients with myeloid malignancies
Platelets
blood platelet disorders
cyclic amp
myelodysplastic syndrome (mds)
myeloid leukemia
platelet function tests
title Acquired platelet dysfunction and overproduction of platelet cyclic AMP in two patients with myeloid malignancies
title_full Acquired platelet dysfunction and overproduction of platelet cyclic AMP in two patients with myeloid malignancies
title_fullStr Acquired platelet dysfunction and overproduction of platelet cyclic AMP in two patients with myeloid malignancies
title_full_unstemmed Acquired platelet dysfunction and overproduction of platelet cyclic AMP in two patients with myeloid malignancies
title_short Acquired platelet dysfunction and overproduction of platelet cyclic AMP in two patients with myeloid malignancies
title_sort acquired platelet dysfunction and overproduction of platelet cyclic amp in two patients with myeloid malignancies
topic blood platelet disorders
cyclic amp
myelodysplastic syndrome (mds)
myeloid leukemia
platelet function tests
url http://dx.doi.org/10.1080/09537104.2019.1636020
work_keys_str_mv AT annalecchi acquiredplateletdysfunctionandoverproductionofplateletcyclicampintwopatientswithmyeloidmalignancies
AT etiafemia acquiredplateletdysfunctionandoverproductionofplateletcyclicampintwopatientswithmyeloidmalignancies
AT silvialamarca acquiredplateletdysfunctionandoverproductionofplateletcyclicampintwopatientswithmyeloidmalignancies
AT francescoonida acquiredplateletdysfunctionandoverproductionofplateletcyclicampintwopatientswithmyeloidmalignancies
AT andreaartoni acquiredplateletdysfunctionandoverproductionofplateletcyclicampintwopatientswithmyeloidmalignancies